DBT- BIRAC COVID-19 Shortlisted Proposals


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ DBT- BIRAC COVID-19 Shortlisted Proposals
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options, two proposals on drug repurposing and 14 projects which are categorised as preventive interventions.

The Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) has invited applications for COVID-19 Research Consortium. In addition to this, under a ‘Fast Track Review Process’ BIRAC has created a provision to fund COVID-19 solutions that are ready for immediate.

DBT and BIRAC has regularly been evaluating applications with different resources in order for developing diagnostics, vaccines, novel therapeutics, repurposing of drugs or any other intervention for control of COVID-19.  Through a rolling multi-tiered review mechanism, 70 proposals of devices, diagnostics, vaccine candidates, therapeutics and other interventions have been recommended for receiving financial support. The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options, two proposals on drug repurposing and 14 projects which are categorised as preventive interventions.

Very soon IIT Indore is going to develop a Pseudo-virus SARS CoV-2 which is useful for the development of in-vitro assays. The whole portfolio of vaccine candidates is now enhanced by providing support for development of next-generation mRNA vaccine candidates by Gennova and also separately to CMC, Vellore for a lipid encapsulated mRNA based vaccine.

The work towards discovering neutralising antibodies from an existing phage display based library and are being supported under National Biopharma Mission of DBT was initiated by the Delhi University, South Campus. BIRAC has also committed to provide their full support for different types of diagnostics platforms. By this many more academic institutes are in the run to resolve the problem of anticipating long term need for diagnostics by their own ways. In total there are among 34 companies and academic institutes are in total, who will receive financial support by different means for ensuring that there is no shortage of indigenous diagnostic kits in the near future.

And also under this initiative, the startups having PPE solutions have been easily approved for supporting manufacturing of ‘Full body coverage suits’ to Aarna Biomedical Products, automated sanitizer to Micro GO and for “Face Shields” to Alpha Corpusles. This is all categorised as preventive interventions.

Tags : #DBT #BIRAC #Covid19 #Vaccine

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026